Spots Global Cancer Trial Database for allopurinol
Every month we try and update this database with for allopurinol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL | NCT02046694 | Acute Lymphobla... | Allopurinol | - 30 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome | NCT00230178 | Tumor Lysis Syn... Cancer Hyperuricemia | Rasburicase (SR... Allopurinol | 18 Years - | Sanofi | |
| A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas | NCT00401388 | Chondrosarcomas Alveolar Soft P... Extra Skeletal ... | Perifosine Loperamide Allopurinol Antiemetics | 13 Years - | AEterna Zentaris | |
| Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies | NCT01724528 | Tumor Lysis Syn... | Febuxostat Allopurinol | 18 Years - | Menarini Group | |
| S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT00109837 | Leukemia | filgrastim cyclophosphamid... cytarabine daunorubicin dexamethasone doxorubicin leucovorin mercaptopurine methotrexate mitoxantrone Asparaginase prednisone thioguanine vincristine radiation thera... allopurinol bactrim | 18 Years - 64 Years | SWOG Cancer Research Network | |
| Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma | NCT00199043 | Adult Acute Lym... High-grade Lymp... | Allopurinol Rasburicase | 15 Years - | Goethe University | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion | NCT03570983 | Multiple Myelom... | Allopurinol Carmustine Etoposide Cytarabine Melphalan | 18 Years - 70 Years | Swedish Medical Center | |
| Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma | NCT00199043 | Adult Acute Lym... High-grade Lymp... | Allopurinol Rasburicase | 15 Years - | Goethe University | |
| T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer | NCT00602693 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | umbilical cord ... Allopurinol fludarabine pho... Cyclophosphamid... Total body irra... Treg infusion Sirolimus | 18 Years - 75 Years | Masonic Cancer Center, University of Minnesota | |
| Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies | NCT01564277 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Contiguous Stag... de Novo Myelody... Noncontiguous S... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Adult... Stage I Adult B... Stage III Adult... Stage IV Adult ... Untreated Adult... Untreated Adult... | rasburicase allopurinol | 18 Years - | Roswell Park Cancer Institute | |
| T-Cell Depleted Double UCB for Refractory AML | NCT01464359 | Acute Myelogeno... Refractory Acut... | Allopurinol Fludarabine Total body irra... Cyclophosphamid... Levetiracetam Busulfan Umbilical Cord ... Interleukin-2 | 2 Years - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT) | NCT05536349 | Leukemia | Pirtobrutinib Obinutuzumab Venetoclax Valacyclovir Allopurinol | 18 Years - | M.D. Anderson Cancer Center | |
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia | NCT00061945 | Acute Undiffere... B-cell Adult Ac... B-cell Childhoo... L1 Adult Acute ... L1 Childhood Ac... L2 Adult Acute ... L2 Childhood Ac... Philadelphia Ch... Philadelphia Ch... Philadelphia Ch... T-cell Adult Ac... T-cell Childhoo... Untreated Adult... Untreated Child... | allopurinol cyclophosphamid... daunorubicin hy... vincristine sul... dexamethasone asparaginase filgrastim imatinib mesyla... methotrexate cytarabine trimethoprim-su... mercaptopurine leucovorin calc... alemtuzumab acyclovir laboratory biom... pharmacological... | 15 Years - | National Cancer Institute (NCI) | |
| Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol | NCT03022747 | Lymphoblastic L... | Allopurinol Standard treatm... | 6 Months - 19 Years | Vastra Gotaland Region | |
| Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) | NCT05049863 | Small-cell Lung... Small Cell Lung... | Mycophenolate M... Allopurinol Irinotecan | 18 Years - | Washington University School of Medicine | |
| Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members | NCT00000703 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Zidovudine Dexamethasone | 19 Years - 69 Years | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 | NCT01200485 | Leukemia Lymphoma | Rasburicase Allopurinol | - | M.D. Anderson Cancer Center | |
| A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma | NCT00000658 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | NCT00039130 | Leukemia Lymphoma | filgrastim rituximab cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate prednisone vincristine sul... Allopurinol | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia | NCT03150693 | B Acute Lymphob... | Allopurinol Cytarabine Daunorubicin Hy... Vincristine Sul... Dexamethasone Pegylated L-Asp... Methotrexate Bone Marrow Asp... Cyclophosphamid... Mercaptopurine Rituximab Doxorubicin Thioguanine Inotuzumab Ozog... Laboratory Biom... | 18 Years - 39 Years | Alliance for Clinical Trials in Oncology | |
| Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) | NCT00899431 | Chronic Lymphoc... | Lenalidomide Fludarabine Rituximab Thymoglobulin Stem Cell Trans... Bendamustine Allopurinol | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia | NCT00003700 | Leukemia | G-CSF asparaginase cyclophosphamid... cytarabine daunorubicin hy... leucovorin calc... mercaptopurine methotrexate prednisone vincristine sul... Allopurinol | 15 Years - | Alliance for Clinical Trials in Oncology | |
| Treatment of Hyperuricemia With Rasburicase in Patients With Acute Lymphoblastic Leukemia or High Grade Lymphoma | NCT00199043 | Adult Acute Lym... High-grade Lymp... | Allopurinol Rasburicase | 15 Years - | Goethe University | |
| Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer | NCT00652899 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | Allopurinol Cyclophosphamid... Fludarabine pho... total-body irra... Allogeneic natu... Aldesleukin | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | NCT00039130 | Leukemia Lymphoma | filgrastim rituximab cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate prednisone vincristine sul... Allopurinol | 16 Years - | Alliance for Clinical Trials in Oncology | |
| A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma | NCT00000658 | Lymphoma, Non-H... HIV Infections | Bleomycin sulfa... Vincristine sul... Doxorubicin hyd... Cyclophosphamid... Allopurinol Methotrexate Cytarabine Leucovorin calc... Sargramostim Dexamethasone | 12 Years - | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies | NCT01724528 | Tumor Lysis Syn... | Febuxostat Allopurinol | 18 Years - | Menarini Group | |
| Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT) | NCT05536349 | Leukemia | Pirtobrutinib Obinutuzumab Venetoclax Valacyclovir Allopurinol | 18 Years - | M.D. Anderson Cancer Center | |
| Busulfan and Cyclophosphamide Followed By ALLO BMT | NCT01685411 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... | Allopurinol Keppra Busulfan Cyclophosphamid... Tacrolimus Mycophenolate m... Allogeneic hema... Filgrastim antithymocyte g... | - 44 Years | Masonic Cancer Center, University of Minnesota |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
